Asiri Hospital Holdings PLC (COSE:ASIR.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Asiri Hospital Holdings Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 34,347 | 31,022 | 28,571 | 24,786 | 22,324 | 15,785 | |
Revenue Growth (YoY) | 14.10% | 8.58% | 15.27% | 11.03% | 41.43% | 1.77% |
Cost of Revenue | 17,019 | 16,315 | 15,024 | 13,119 | 11,923 | 8,995 |
Gross Profit | 17,328 | 14,707 | 13,548 | 11,667 | 10,401 | 6,790 |
Selling, General & Admin | 11,276 | 10,557 | 10,712 | 5,982 | 4,828 | 4,183 |
Operating Expenses | 11,276 | 10,557 | 10,712 | 5,982 | 4,828 | 4,183 |
Operating Income | 6,052 | 4,150 | 2,836 | 5,685 | 5,572 | 2,607 |
Interest Expense | -1,939 | -1,988 | -3,571 | -5,135 | -1,252 | -1,407 |
Interest & Investment Income | 1,511 | 1,259 | 1,648 | 2,437 | 240.13 | 242.33 |
Earnings From Equity Investments | 69.31 | 69.31 | 66.99 | 64.78 | - | - |
Currency Exchange Gain (Loss) | 3.46 | 3.46 | -2.2 | 13.61 | 22.58 | 4.63 |
Other Non Operating Income (Expenses) | 161.55 | 159.75 | 157.08 | 131.44 | 183.36 | 138.12 |
EBT Excluding Unusual Items | 5,859 | 3,654 | 1,135 | 3,197 | 4,767 | 1,585 |
Gain (Loss) on Sale of Investments | 0.46 | 0.46 | - | 0.43 | 7.08 | 30 |
Gain (Loss) on Sale of Assets | -2.22 | -2.22 | -2.03 | -2.39 | -1.57 | -3.88 |
Pretax Income | 5,857 | 3,652 | 1,133 | 3,195 | 4,772 | 1,611 |
Income Tax Expense | 1,882 | 1,826 | 1,250 | 1,496 | 968.9 | -133.64 |
Earnings From Continuing Operations | 3,975 | 1,826 | -117.24 | 1,699 | 3,803 | 1,745 |
Minority Interest in Earnings | -236.58 | -182.24 | -97.75 | -230.31 | -299.36 | -213.38 |
Net Income | 3,738 | 1,644 | -214.99 | 1,469 | 3,504 | 1,531 |
Net Income to Common | 3,738 | 1,644 | -214.99 | 1,469 | 3,504 | 1,531 |
Net Income Growth | - | - | - | -58.08% | 128.83% | 89.51% |
Shares Outstanding (Basic) | 1,135 | 1,138 | 1,138 | 1,138 | 1,138 | 1,138 |
Shares Outstanding (Diluted) | 1,135 | 1,138 | 1,138 | 1,138 | 1,138 | 1,138 |
Shares Change (YoY) | -0.48% | - | - | - | - | - |
EPS (Basic) | 3.29 | 1.44 | -0.19 | 1.29 | 3.08 | 1.35 |
EPS (Diluted) | 3.29 | 1.44 | -0.19 | 1.29 | 3.08 | 1.35 |
EPS Growth | - | - | - | -58.08% | 128.83% | 89.51% |
Free Cash Flow | 3,527 | 1,028 | 3,281 | 1,680 | 4,307 | 1,181 |
Free Cash Flow Per Share | 3.11 | 0.90 | 2.88 | 1.48 | 3.79 | 1.04 |
Dividend Per Share | - | 1.500 | - | - | 2.500 | 1.600 |
Dividend Growth | - | - | - | - | 56.25% | - |
Gross Margin | 50.45% | 47.41% | 47.42% | 47.07% | 46.59% | 43.02% |
Operating Margin | 17.62% | 13.38% | 9.93% | 22.94% | 24.96% | 16.52% |
Profit Margin | 10.88% | 5.30% | -0.75% | 5.93% | 15.70% | 9.70% |
Free Cash Flow Margin | 10.27% | 3.31% | 11.48% | 6.78% | 19.29% | 7.48% |
EBITDA | 7,882 | 5,926 | 4,584 | 7,266 | 6,963 | 3,949 |
EBITDA Margin | 22.95% | 19.10% | 16.04% | 29.32% | 31.19% | 25.02% |
D&A For EBITDA | 1,830 | 1,776 | 1,748 | 1,581 | 1,391 | 1,342 |
EBIT | 6,052 | 4,150 | 2,836 | 5,685 | 5,572 | 2,607 |
EBIT Margin | 17.62% | 13.38% | 9.93% | 22.94% | 24.96% | 16.52% |
Effective Tax Rate | 32.13% | 50.01% | 110.35% | 46.82% | 20.30% | - |
Advertising Expenses | - | 286.04 | 329.33 | 379.39 | 150.43 | 150.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.